FDA OK's genetic predictor of breast cancer relapse
615464
The Food and Drug Administration yesterday approved a genetic test that, when conducted soon after a woman learns she has breast cancer, can predict the odds of the disease returning and worsening.
133597
TUESDAY, Feb. 6 (HealthDay News) -- The U.S. Food and Drug Administration has approved a test designed to predict the chances of breast cancer returning or spreading within five to 10 years after a woman's initial cancer.
426608
A new test invented by a Redwood City medical laboratory can accurately predict which women are likely to have a recurrence of breast cancer and whether they need to undergo debilitating chemotherapy to avoid it.
229876
New findings add to the evidence that genetic tests can help predict whether breast cancer will recur, giving valuable guidance to doctors and patients about whether potentially toxic chemotherapy
372786
U.S. health officials approved a genetic test on Tuesday that can provide women with early breast cancer an estimate of whether the disease is likely to return in five to 10 years.
304755
TORONTO - A standard treatment used to prevent the recurrence of breast cancer should be replaced by a newer drug, according to a study released Wednesday.
185930
U.S. regulators cleared a new genetic test on Monday that helps predict tumor recurrence and long-term survival in breast cancer patients with higher risk of the cancer returning.
272151
The criteria on who to test for a high-risk breast cancer gene should be reviewed, researchers suggest.
636717
Tiny differences in genes linked to  the hormone estrogen can strongly influence a woman's risk of  developing breast cancer, U.S. researchers reported on  Wednesday.
256613
(letrozole) is the first therapy approved by theU.S. Food and Drug Administration (FDA) for the extended adjuvant treatmentof postmenopausal women with early breast cancer who have received adjuvant(post-surgery) tamoxifen therapy for five years
423731
Researchers who found a genetic  pattern that predicts who will be helped by a revolutionary new  lung cancer drug said on Monday they were looking for patients  to help them confirm their findings.
221557
Scientists have identified a gene  variation found in about 13 percent of women of European  descent that reduces their risk of developing breast cancer, a  study released on Sunday said.
134401
A drug currently prescribed to combat advanced breast cancer can now be used to help prevent the disease from recurring in women who have been treated for early forms of the disease, the US Food and Drug Administration ruled Friday.
119495
A genetic test for patients with early breast cancer can identify that only some of them will be helped by chemotherapy, but for those women the benefits far outweigh the drawbacks, researchers said on Friday.
25183
Scientists in Britain have identified a  genetic mutation involved in certain types of lung cancer and  said the breast cancer drug Herceptin might work in patients  who have it.
643980
NEW YORK  - The American Society of Clinical Oncology (ASCO) now recommends that a third-generation aromatase inhibitor be included as adjuvant hormonal therapy for postmenopausal women with receptor-positive breast cancer.
435359
Description: Researchers meeting in San Antonio are reporting promising results about a new genetic test that can predict which breast cancer patients will benefit from chemotherapy.